Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VHLL Protein (AA 1-154) (His tag)

VHLL Origine: Humain Recombinant > 95.0 % as determined by SDS-PAGE.
N° du produit ABIN620853
  • Antigène Voir toutes VHLL Protéines
    VHLL (Von Hippel-Lindau Tumor Suppressor-Like (VHLL))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 1-154
    Origine
    Humain
    Hôte
    Veuillez nous consulter SVP
    Purification/Conjugué
    Cette VHLL protéine est marqué à la His tag.
    Séquence
    MGSSHHHHHH SSGLVPRGSH MPRRAENWDE AEVGAEEAGV EEYGPEEDGG EESGAEESGPEESGPEELGA EEEMEAGRPR PVLRSVNSRE PSQVIFCNRS PRVVLPVWLN FDGEPQPYPT LPPGTGRRIH SYRGHLWLFR DAGTHDGLLV NQTELFVPSL NVDGQPIFAN ITLP.
    Attributs du produit
    Recombinant Human Von Hippel-Lindau Protein
    Pureté
    > 95.0 % as determined by SDS-PAGE.
    Top Product
    Discover our top product VHLL Protéine
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    The Von Hippel-Lindau Protein contains 1x PBS pH-7.4, 2mM EDTA, and 1mM DTT.
    Stock
    4 °C
  • Antigène
    VHLL (Von Hippel-Lindau Tumor Suppressor-Like (VHLL))
    Autre désignation
    Von Hippel-Lindau Protein (VHLL Produits)
    Synonymes
    VHLP Protein, VLP Protein, VHL like Protein, VHLL Protein
    Sujet
    Recombinant Human Von Hippel-Lindau Protein b-domain produced in E. coli is a single, non-glycosylated polypeptide chain containing 174 AA (1-154) and having a molecular mass of 19.2 kDa. The Von Hippel-Lindau antigen is fused to 20 AA His-Tag at N-terminus and purified by proprietary chromatography techniques. Introduction: Von Hippel-Lindau disease is a dominant inherited syndrome characterized by the predisposition to develop various kinds of benign and malignant tumors, including clear cell renal carcinomas, pheochromocytomas and hemangioblastomas of the central nervous system and retina. VHL syndrome is caused by germline mutation in the VHL tumor suppressor, and VHL tumors are associated with loss or mutation of the remaining wild-type allele. VHL has two domains: a roughly 100-residue NH2-terminal domain rich in b sheet (b-domain) and a smaller a-helical domain (a-domain), held together by two linkers and a polar interface. VHL protein is also involved in the degradation of hypoxia-inducible factor (HIF). Synonyms: Von Hippel-Lindau disease tumor suppressor, pVHL, Protein G7, VHL, RCA1, VHL1, HRCA1.
Vous êtes ici:
Support technique